shortagewatch

Home / Genito-urinary system and sex hormones / Medroxyprogesterone

ATC G03AC06 · Progestogens · updated 4 Nov 2026

Medroxyprogesterone shortage

As of 4 Nov 2026, Medroxyprogesterone has a reported shortage in 2 of the 16 countries we track (United States, Australia), covering 3 products from 1 company.

Is there a Medroxyprogesterone shortage?

Yes. As of 4 Nov 2026, Medroxyprogesterone is reported short in 2 of the 16 countries we track: United States, Australia. The earliest expected return is 4 Jan 2027 (Australia). 2 of 3 affected products have no return date.

Countries2/16
Products3packs or presentations
Companies11 listed
Short since31 Aug 20262 months ago
Earliest return4 Jan 2027company estimate
Main reasonNot stated
Free. One email on days with changes. Unsubscribe in one click. Privacy.
United States2 products shortCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustralia1 product short

Timeline

United StatesAustralia
PROVERA, Tablet, 10 mg (NDC 0009-0051-01)PROVERA, Tablet, 10 mg (NDC 0009-0051-01)PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer2 PFE

Listed: Pfizer PFE · NYSE

Compared with similar medicines

ATC group G03AC · Progestogens
Medroxyprogesterone2/16Desogestrel1/16Etonogestrel1/16Levonorgestrel1/16Norethisterone1/16

Affected products

CountryProductCompanySinceExpected backReason
USPROVERA, Tablet, 10 mg (NDC 0009-0051-01) discontinuationPfizer Inc.31 Aug 2026not givenNot stated
USPROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) discontinuationPfizer Inc.31 Aug 2026not givenNot stated
AURALOVERA medroxyprogesterone acetate 5mg tablet blister pack anticipated23 Nov 20264 Jan 2027Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Medroxyprogesterone shortage?

Yes. As of 4 Nov 2026, Medroxyprogesterone is reported short in 2 of the 16 countries we track: United States, Australia. The earliest expected return is 4 Jan 2027 (Australia). 2 of 3 affected products have no return date.

When will Medroxyprogesterone be back in stock?

Companies expect supply back from 4 Jan 2027 in Australia; United States: no date given; Australia: 4 Jan 2027. These are company estimates reported to each authority.

Why is Medroxyprogesterone in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Medroxyprogesterone shortages?

Pfizer.